-
-
-
-
-
-
-
Relmada Therapeutics (RLMD) Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
-
-
-
-
-
-
-
Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
-
-
-
-
-
-
-
Relmada Therapeutics Recommends Stockholders Vote "FOR" Relmada's Director Nominees on the WHITE Proxy Card Today
-
-
-
1,159,115 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

